Deutsche BankAflac
Live Report · Updated April 10, 2026

Deutsche Bank vs Aflac

Deutsche Bank is one of Germany's systemic financial institutions carrying investment banking, corporate banking, and private wealth management operations across a global footprint still repairing its...

Why It's Moving

Deutsche Bank

Analysts Eye +27% DB Upside as Deutsche Bank Powers into 2026 with Robust Profit Forecasts.

  • Profit projections leap 11% to €6.6 billion in 2026, building on 2025's €5.9 billion beat and highlighting sustained revenue momentum in corporate banking.
  • Revenue set to climb 2.76% to €33.2 billion, driven by loan growth and €78 billion in asset management inflows despite rate stabilization.
  • Strategic pivot to 13% RoTE target by 2028 positions DB as a reliable capital return machine, moving beyond legacy issues to market-leading returns.
Sentiment:
🐃Bullish

Investment Analysis

Pros

  • Deutsche Bank maintains a leading global position in foreign exchange trading with a market share of around 20%.
  • The bank has diversified operations across five business segments, including asset management and corporate banking, supporting revenue resilience.
  • Recent analyst consensus forecasts a moderate upside in the share price, supported by improving economic outlooks and fiscal stimulus.

Considerations

  • Deutsche Bank's valuation metrics indicate a relatively high current P/E ratio compared to projected future earnings, suggesting potential overvaluation.
  • The bank faces ongoing regulatory and macroeconomic risks, including exposure to higher US interest rates and a stronger dollar.
  • Capital-intensive asset reduction efforts in its non-core operations continue to constrain profitability and capital deployment flexibility.

Pros

  • Aflac is a global leader in supplemental health and life insurance, with a strong presence in both the US and Japanese markets.
  • The company benefits from a diversified product portfolio, with cancer insurance accounting for nearly half of its policies.
  • Aflac has a long-standing reputation for innovation, having pioneered cancer insurance globally in 1958.

Considerations

  • Aflac's business is highly dependent on the US and Japanese economies, making it sensitive to regional economic downturns.
  • The company faces intense competition from other major insurers in both its core markets, pressuring margins and growth.
  • Regulatory changes in healthcare and insurance sectors could impact Aflac's profitability and operational flexibility.

Deutsche Bank (DB) Next Earnings Date

Deutsche Bank's next earnings date is April 29, 2026, covering the Q1 2026 results as of March 31, 2026, with an investor and analyst conference call. This date aligns with the company's official financial calendar and recent analyst projections following the prior Q4 2025 release on January 29, 2026. Investors should monitor for any updates, as dates remain subject to confirmation.

Buy DB or AFL in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

DB
DB$32.44
vs
AFL
AFL$108.73